Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research
Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE, Nov. 13, 2025 /PRNewswire/ -- Agilent Technologies Inc. (NYSE:...
Read more




